KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Discontinued OperationsCash from Discontinued OperationsCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TherapeuticsMD (TXMD) Cash from Operations (2016 - 2026)

TherapeuticsMD filings provide 17 years of Cash from Operations readings, the most recent being 944000.0 for Q1 2026.

  • On a quarterly basis, Cash from Operations rose 35.05% to 944000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was 2699000.0, a 28.65% increase, with the full-year FY2025 number at 2454000.0, up 109.74% from a year prior.
  • Cash from Operations hit 944000.0 in Q1 2026 for TherapeuticsMD, up from 375000.0 in the prior quarter.
  • In the past five years, Cash from Operations ranged from a high of 30236000.0 in Q4 2022 to a low of 20721000.0 in Q2 2022.
  • Median Cash from Operations over the past 5 years was 17000.0 (2024), compared with a mean of 538470.59.
  • Biggest five-year swings in Cash from Operations: plummeted 134.03% in 2023 and later skyrocketed 2105.88% in 2025.
  • TherapeuticsMD's Cash from Operations stood at 30236000.0 in 2022, then tumbled by 116.4% to 4960000.0 in 2023, then soared by 100.34% to 17000.0 in 2024, then skyrocketed by 2105.88% to 375000.0 in 2025, then soared by 151.73% to 944000.0 in 2026.
  • The last three reported values for Cash from Operations were 944000.0 (Q1 2026), 375000.0 (Q4 2025), and 999000.0 (Q3 2025) per Business Quant data.